• Trending
  • Latest
    Sign in Sign up
    • Log In
    • Register
    • Home
    • Discover
    • Experts
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Mashup Score: 2
      Optimizing nAMD and DME Treatment: Real-World Durability, and Fluid Outcomes with Second Generation Anti-VEGF Agents - 4 day(s) ago

      HCPLive is a clinical news and information portal, offering physicians specialty and disease-specific resources, conference coverage, and interviews.

      Source: www.hcplive.com
      Categories: General Medicine News
      Tweet Tweets with this article
      • Profile photo of 	MDMagazine
        MDMagazine

        Achieving long-term control in nAMD & DME means looking beyond efficacy. Explore durability, fluid outcomes & real-world strategies in this expert Medcast. Listen now: https://t.co/YHeAbvh2UP #Retina #nAMD #DME #Ophthalmology #AntiVEGF https://t.co/ndQd08cQeR

    ASCO 2025

    Advertisement

    Advertisement

    MashupMD
    © 2025 - Mashup Media LLC
    • Terms of Use
    • Privacy Policy
    • Cookie Settings